Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to identify patients with chronic hepatitis C virus (HCV) who were lost of follow up and relinkage them to hepatitis C care


Clinical Trial Description

The investigators will review electronic medical charts to identify patients with HCV diagnosis. Next, investigators will evaluate if these patients are routinely followed by liver specialists at the Institution. Those patients who were lost of follow up will be reached to evaluate their disease and eventually offer them to restart HCV care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04470271
Study type Observational [Patient Registry]
Source Austral University, Argentina
Contact Manuel Mendizabal, MD
Phone +5491140332244
Email mmendiza@cas.austral.edu.ar
Status Not yet recruiting
Phase
Start date September 1, 2020
Completion date March 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT03537196 - DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) Phase 4
Recruiting NCT05751889 - Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM N/A
Completed NCT03566966 - Autoantibodies and Direct-acting Antivirals
Completed NCT04047680 - eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs
Not yet recruiting NCT04690972 - "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Active, not recruiting NCT01953458 - Therapeutic Option for Hepatitis B and C: a French Cohort
Completed NCT02125500 - Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection Phase 2
Withdrawn NCT01766115 - Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers Phase 4